Rejuvenation Technologies
PrivateLast Round
Early Funding
Sep 24, 2026
Est. Valuation
$1.71M
Total Funding Raised
$18.27M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Rejuvenation Technologies is a biotechnology company developing mRNA-based therapeutics and lipid nanoparticle delivery vehicles to extend telomeres and treat age-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rejuvenation Technologies Comparables
Compare Rejuvenation Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Turn Biotechnologies | 86% | |
| Telomere Therapeutics | 79% | |
| Oisín Biotechnologies | 76% |
Rejuvenation Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Sep 24, 2026 | ||||
| Grant | Sep 4, 2024 | ||||
| Grant | Aug 1, 2024 | ||||
| Grant | Jul 26, 2024 | ||||
| Seed | Sep 6, 2023 | ||||
Grant | Jan 26, 2023 |
Rejuvenation Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of Health and Human Services | Grant |
| Khosla Ventures | Seed |
| NIH RADx | Grant |
| Longevitytech.fund | Seed |
| National Institute on Aging | Grant |
| California Institute for Regenerative Medicine | Grant |
| Asymmetry Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 24, 2026
Raised capital from Xcellerant Ventures.
- Jul 27, 2026
Monthly visitors increased 79% MoM, reaching 1.5K.
Rejuvenation Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Rejuvenation Technologies's valuation, stock price, and market status.
Is Rejuvenation Technologies a public or private company?
Rejuvenation Technologies is a private company.
What is the current stock price of Rejuvenation Technologies?
Rejuvenation Technologies is a private company, so its shares have no public market price. Caplight tracks Rejuvenation Technologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Rejuvenation Technologies worth (valuation)?
Rejuvenation Technologies's valuation is estimated at $1.7M based on funding round data.
Can I buy Rejuvenation Technologies stock?
Rejuvenation Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Rejuvenation Technologies's last funding round?
Rejuvenation Technologies's most recent funding round was Early Funding on September 24, 2026.
Who are the main investors in Rejuvenation Technologies?
Key investors in Rejuvenation Technologies include Khosla Ventures, Y Combinator.
Will Rejuvenation Technologies IPO soon?
No public IPO plans have been announced for Rejuvenation Technologies.
How can I track Rejuvenation Technologies secondary market activity?
Caplight tracks bids, offers, and trades in Rejuvenation Technologies's shares on secondary markets.